Omixon Receives IVDR approval for NanoTYPE™ CE IVDR Pioneering Transplant Diagnostic with the First CE IVDR Kit based on Oxford Nanopore Technologies

11/06/2024

Press Release June 11, 2024 Budapest, Hungary Omixon Receives IVDR approval for NanoTYPE™ CE IVDR Pioneering Transplant Diagnostic with the First CE IVDR Kit based on Oxford Nanopore Technologies Omixon has received In Vitro Diagnostic Regulation (IVDR) approval of NanoTYPE™, an innovative high resolution multiplex 11 loci...

Omixon Launches NanoTYPE^TM RUO, a Multiplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinION^TM Platform and Enters into an Agreement with Oxford Nanopore Technologies

26/09/2022

High resolution histocompatibility testing for urgent transplant cases made possible within five hours turnaround time. Budapest, Hungary, September 27, 2022. Omixon Biocomputing, Ltd announced today the launch of NanoTYPE^TMRUO, a multiplex 11 loci human leukocyte antigen (HLA) amplification kit and the complementary NanoTYPER^TMsoftware compatible with Oxford Nanopore’s...

Editorial Board Award – Human Immunology

10/05/2022

Each year, the Human Immunology editorial board awards the best original research papers and the best review papers from two years previous. The top papers in each category published in 2020 were chosen based on citation and download statistics gathered from 2021. The papers were then voted on by...